The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys

Table 2 Median price of adult dosages in tablet form among the different antimalarial brands in outlets disaggregated by region (north–south), area (rural–urban) and outlet type (pharmacy-PPMV) as well as by type of antimalarial

Brand name	Type	# tablets in AETD	Median cost (NGN)
Brand name	Type	# tablets in AETD	North	South	Rural	Urban	Pharm-acy	PPMV	Average cost of brand/ type overall
Amalar	Non-ACT antimalarial	3	150	180	200	150	150	180	170
Amalar Plus	Non-ACT antimalarial	9	325	300	400	300	350	300	300
Camosunate	Non-green leaf ACT (ds)	6	600	600	525	600	600	500	600
Coartem	Green leaf ACT	24	350	600	480	600	600	490	500
Coartem DS	Non-green leaf ACT (ds)	6	1650	1600	1700	1650	1600	1800	1650
Combisunate	Green leaf ACT	24	300	400	350	330	330	350	350
Combisunate DS	Non-green leaf ACT (ds)	6	500	550	500	600	600	550	550
Lonart	Non-green leaf ACT (ss)	24	500	500	500	500	500	500	500
Lonart DS	Non-green leaf ACT (ds)	6	1100	1200	1000	1200	1200	1100	1200
Lumartem	Green leaf ACT	24	350	600	600	600	650	600	600
P-Alaxin	Non-green leaf ACT (ds)	9	800	850	800	850	850	800	845
Median by type	All brands		550	650	500	700	718	500	600
	Green leaf ACT		350	600	450	600	600	450	500
	Non-ACT antimalarial		150	200	200	170	155	200	180
	Non-green leaf ACT (ds)		1000	865	800	950	950	800	900
	Non-green leaf ACT (ss)		500	500	500	500	500	500	500

AETD adult equivalent treatment dose, ds double-strength, ss standard-strength

ISSN: 1475-2875